<DOC>
	<DOCNO>NCT00306033</DOCNO>
	<brief_summary>This study double-blind , placebo-controlled , randomized clinical trial determine whether IVIG effective improve motor score patient myasthenia gravis worsen weakness .</brief_summary>
	<brief_title>Intravenous Immune Globulin Treatment Compared Placebo Patients With Myasthenia Gravis</brief_title>
	<detailed_description>Patients age 18 year old diagnosis myasthenia gravis ( MG ) worsen weakness enrol study provide informed consent . Fifty-two patient recruit study , one withdrew consent prior start 51 patient recruit . Baseline clinical assessment use Quantitative MG Score Disease Severity ( QMGS ) repeat 2 4 week treatment IVIG saline infusion . The Post-Intervention Status assess 2 4 week treatment . The treatment randomize double-masked . Electrophysiological immunological test do baseline 2 week . Baseline characteristic compare Student 's test continuous variable Chi-square test categorical variable . An analysis covariance perform primary outcome measure , change QMGS .</detailed_description>
	<mesh_term>Muscle Weakness</mesh_term>
	<mesh_term>Myasthenia Gravis</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>age &gt; equal 18 year old confirm diagnosis myasthenia gravis worsen weakness age &lt; 18 ; severe myasthenia gravis require intensive care admission ; change immunosuppresive medication previous 3 month ; patient severe bulbar weakness risk aspiration respiratory failure ; patient serious underlying medical condition ( renal failure , congestive heart failure ) ; unwilling provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2005</verification_date>
	<keyword>myasthenia gravis</keyword>
	<keyword>immunoglobulin</keyword>
	<keyword>intravenous immunoglobulin</keyword>
	<keyword>treatment</keyword>
</DOC>